Product Code: RP-ID-10151774 |
Published Date: 21 Oct 2022 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151774
Market Overview:
Global Respiratory Disease Testing/Diagnostics Industry Market Research 2030
The global Respiratory Disease Testing and Diagnostics market is expected to be valued at ~USD 9 billion in 2021 and is projected to grow at a consolidated CAGR of ~4% during the forecast period 2022-2030. The spread of respiratory diseases due to the increase in air pollution is one of the major drivers of the market growth. According to the Centers for Disease Control and Prevention (CDC), chronic obstructive pulmonary disease (COPD) was the third leading cause of death in the United States in 2014 due to air pollutant levels and the release of harmful gases from the lungs. Included: Done. COPD and worldwide. Other respiratory diseases. The market is ruled by the world. Other factors promoting overall growth include the prevalence of infectious diseases such as tuberculosis and nosocomial infections. These tests serve as the primary diagnostic tool and are likely imaging tests such as computed tomography (CT). 'Used to diagnose growth factors. High-tech devices, such as pulse oximeters, are becoming increasingly popular for the effective treatment of COPD in outpatients. Non-invasive mechanical replacement of COPD is also expected to drive the market growth. Product Information: In 2020, imaging tests accounted for the majority of global airway test sales. The main reason this section is effective is the increasing use of X-rays and other imaging techniques to improve visual and clear images of disease. Also, the demand for computed tomography is expected to increase. As a result, the segment is expected to maintain its dominance over the forecast period. Respiratory flow meters, also known as spirometers, include spirometers, pulse oximeters, flowcharts, and peak flow meters. The demand for pulse oximeters in this industry is increasing compared to other devices. Accurate and effective diagnosis is expected to advance the field in the short term during the forecast period. Final Health Consumption Overview had the highest sales in 2020: The installation and use of advanced airway diagnostic equipment such as x-ray equipment in hospitals and spirometers such as spirometers, pulse oximeters and ventilators will increase sales. Doctors prefer to be hospitalized rather than referred to an outpatient laboratory. Hospitals with the highest number of patients are also the best-selling segments of the market. The medical clinic segment is expected to grow significantly during the forecast period. Regional Outlook: North America held the largest market share in 2020 with over 25%. The high prevalence of respiratory diseases such as COPD, asthma and other respiratory infections is one of the leading causes of dominance in North America. The growing popularity of portable devices such as advanced lung activity monitors and non-invasive ventilators is also driving the growth, with Asia and Oceania expected to register the fastest growth during the forecast period. This growth is primarily due to increased patient awareness of better healthcare infrastructure and availability of diagnostic methods. In addition, the spread of respiratory diseases, boom in the medical tourism sector, and increased investment from regional market players are expected to underpin the growth of the Asia Pacific and Latin American markets. The sections included in this report report global, regional and national sales growth forecasts and provide analysis of the latest industry trends and opportunities in each sub sector from 2022-2030. In this study, Kenneth Research, Global Product -Based Disease Testing Market, Applications and Final Areas and Scope: Product Forecast (Sales, USD 1M, 2022-2030) Imaging Tests, Respiratory Measurements, Blood Gas Testing, Nasal Observations and Other Articles (Sales, USD 1M, 2022-2030) Hospital Medical Clinic and Medical Lab.
Related Reports
Proof of Quality & Reliability
